ArticleBiochemistry and biophysics reports2026
Restoration of oxidative stress by HNF4α deletion in VWA8-null hepatocytes.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
VWA8 is a mitochondrial protein expressed at high levels in mitochondria-enriched organs such as the liver, kidney, and heart. Deletion of VWA8 (VWA8-KO) in AML12 mouse hepatocytes leads to oxidative stress characterized by elevated production of reactive oxygen species (ROS) and, subsequently, higher oxidative capacity. Concurrently, there is a substantial rise in the expression of the transcription factor HNF4α in VWA8-KO hepatocytes. Thus, exploring the potential significance of HNF4α in the observed effects warrants investigation. In this study, we deleted the HNF4α gene using CRISPR/Cas9 in VWA8-KO AML12 mouse hepatocytes. Measurements of ROS production rates, MitoStress Assays in permeabilized cells, and MitoStress Assays in intact cells were performed. Our results show that Deleting HNF4α in VWA8-KO AML12 mouse hepatocytes (V&H-KO) rescued the increased rate of ROS production observed in VWA8-KO cells, returning ROS to levels comparable to wild-type cells, thereby reversing the oxidative stress associated with VWA8-KO. Furthermore, V&H-KO recovered the elevated respiration rates observed in VWA8-KO intact cells and permeabilized cells when fueled by palmitate, lowering them to wild-type levels. However, the increased respiration rate in VWA8-KO intact cells when using glucose as the fuel source remained unaltered by V&H-KO. This suggests that HNF4α plays an important role but is not the sole factor contributing to the phenotypic changes resulting from VWA8-KO. We conclude that deleting HNF4α in VWA8-KO AML12 mouse hepatocytes partially rescues the higher oxidative capacity and rescues the oxidative stress in VWA8-KO cells. Mechanisms involved in changes in oxidative stress remain to be determined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.